Zobrazeno 1 - 10 of 53 pro vyhledávání: '"J Hohneker"'
1
[Untitled]
Autor: L. Rogers, M. Eble, E. Vokes, Carlos Bazan, J. Hohneker, P. Vilk, P. Z. New
Publikováno v: Investigational New Drugs. 15:343-352
A total of 26 patients (6 with anaplastic astrocytoma; 20 with glioblastoma) were treated with crisnatol mesylate. All patients had residual or progressive disease following surgery and standard radiotherapy; nine patients had prior chemotherapy. Cri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::52ddb43bef29d946e05770649604da99
https://doi.org/10.1023/a:1005968700694
Zobrazit plný text záznamu
2
A phase I/II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma
Autor: J, Viallet, M A, Brassard, L, Souhami, J, Ayoub, P, Del Vecchio, H, Kreisman, J, Guerra, J, Gruber, A, Langleben, J, Hohneker, P, Rousseau
Publikováno v: Cancer. 85(12)
Both locoregional and distant disease control remains poor in the treatment of Stage III nonsmall cell lung carcinoma (NSCLC). This trial was conducted to evaluate the tolerance and responses of patients with NSCLC given a neoadjuvant regimen of cisp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c3642523b44cf2472cc9536bba55aff5
https://pubmed.ncbi.nlm.nih.gov/10375103
Zobrazit plný text záznamu
3
Long-term response to crisnatol mesylate in patients with glioma
Autor: P, New, E, Vokes, L, Rogers, C, Bazan, J, Hohneker, M, Eble, P, Vilk
Publikováno v: Investigational new drugs. 15(4)
A total of 26 patients (6 with anaplastic astrocytoma; 20 with glioblastoma) were treated with crisnatol mesylate. All patients had residual or progressive disease following surgery and standard radiotherapy; nine patients had prior chemotherapy. Cri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0bf06b7265cac7727018601f41766784
https://pubmed.ncbi.nlm.nih.gov/9547677
Zobrazit plný text záznamu
4
Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer
Autor: J Hohneker, J H Schiller, A Koletsky, M O'Rourke, C H Spiridonitis, Ralph W deVere White, C H Spiridonidis, L Hutchins, H Ozer, S Yanovich, A Langleben, S Burman, Jeffrey Crawford, G Clamon
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 14(10)
PURPOSE This prospective randomized trial was performed to compare the effectiveness of intravenous vinorelbine tartrate with intravenous fluorouracil and leucovorin (5-FU/LV) on the primary end points of survival, quality of life (QOL), and relief o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf44361a1751f33e3013956f430f3ef5
https://pubmed.ncbi.nlm.nih.gov/8874320
Zobrazit plný text záznamu
5
Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer
Autor: J, Viallet, J, Ayoub, P, Rousseau, L, Souhami, J, Hohneker, F, Shepherd
Publikováno v: Seminars in oncology. 21(5 Suppl 10)
Several Canadian centers are studying the favorable activity and toxicity profile of vinorelbine (Navelbine; Burroughs Wellcome Co, Research Triangle Park, NC; Pierre Fabre Médicament, Paris, France) in current and future trials of adjuvant and neoa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::62be657f2cc4061ae66eedecdf6c50a1
https://pubmed.ncbi.nlm.nih.gov/7973771
Zobrazit plný text záznamu
7
High-dose (HD) imatinib in patients (pts) with previously untreated chronic myeloid leukemia (CML) in early chronic phase (CP): preliminary results of a multicenter community based trial
Autor: J. Hohneker, Stuart L. Goldberg, Francis J. Giles, Bayard L. Powell, J. E. Cortes, A. Salvado, M. Albitar, I. Sams, Hagop M. Kantarjian
Publikováno v: Journal of Clinical Oncology. 23:6518-6518
6518 Background: A recent single center study suggests that using HD imatinib (800 mg/day) results in significant molecular responses for many patients. We therefore initiated a multicenter communi...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8cd15a66764d40c74e16b8f9792ccff1
https://doi.org/10.1200/jco.2005.23.16_suppl.6518
Zobrazit plný text záznamu
8
1083 A completed phase I/II trial of neoadjuvant chemotherapy (CT) with cisplatin and vinorelbine followed by accelerated thoracic irradiation, (TRT) in inoperable NSCLC
Autor: J Hohneker, J Viallet, P Rousseau, Luis Souhami, J. Ayoub, J. Guerra, H. Kreisman, W. Kerby, P. Del Vecchio, A. Langleben, W. Hunt, B. Leyland-Jones
Publikováno v: European Journal of Cancer. 31:S226
Goal To improve local control by accelerating the delivery of TRT. Design Inoperable and measurable stages II, Ill-A and B NSCLC, KS ≥ 70. Prior weight loss allowed. Treatment cisplatin 100 mg/m2 week 1 and 5, vinorelbine 30 mg/m2 weekly × 5 (15 m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4c1030f7bea4d0bb7c552bfa41eea330
https://doi.org/10.1016/0959-8049(95)96329-c
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje